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Abstract 
We here report the development of an aptamer based biosensor for the investigation of prostate 
specific antigen (PSA), a biomarker found in blood for prostate cancer (PCa), using electrochemical 
impedance spectroscopy (EIS). The study concentrates on a clinical application where a specific and 
sensitive label-free detection could be performed in real blood samples using EIS. Two types of PSA 
aptasensor were fabricated by immobilizing (i) a self-assembled monolayer comprising of 6-
mercaptohexanol (MCH) and thiolated-DNA aptamer and (ii) 11-mercaptoundecanoic acid for 
covalent immobilization of amine terminated DNA aptamers and sulfo-betaine terminated thiol as an 
antifouling agent on a polycrystalline gold surface. Upon incubation of PSA with the DNA aptamer-
based biosensor a decrease of charge transfer resistance (Rct) was observed due to the partial screening 
of the DNA aptamer charge by PSA. Thiol terminated sulfo-betaine based sensors can detect PSA 
levels lower than 1 ng/ml. Validation of the aptasensor is provided by surface plasmon resonance 
measurements. Sulfo-betaine moiety also prevents any significant non-specific binding of the control 
protein human serum albumin (HSA) as compared to high non-specific binding with MCH-based 
sensors. A debate is presented on the effect of the measurement buffer on the values and the direction 
of Rct changes on the aptasensors and the need to cautiously select suitable measurement conditions in 
order to obtain reliable results. This is the first report to date where a DNA aptamer-based biosensor 
was developed using thiol-terminated sulfo-betaine, which is a simple surface chemistry for the 
development of promising, cost-effective, label-free and sensitive electrochemical detection platforms 
for a range of analytes. 
 
Keywords: DNA aptamers; prostate specific antigen; electrochemical impedance spectroscopy; 
antifouling properties 
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1. Introduction 
One of the biggest challenges in the field of cancer detection is its early diagnosis before it metastases 
to other organs. Detection of biomarkers – i.e. biochemical blueprints of a certain disease that can be 
found in altered levels in blood, urine, tissue and saliva – could be used as a method for early 
diagnosis of the disease, leading to more successful treatments [1,2]. Among cancer concerning men 
worldwide, prostate cancer (PCa) makes its mark as one of the leading causes of cancer related 
morbidity among men over 50 years of age [3]. PCa can be very lethal, as it lacks any symptoms in its 
early stage and is incurable if diagnosed in its later stages [4]. The most frequently used biomarker in 
blood to detect and monitor patients with PCa is prostate specific antigen (PSA). It is a 30-34 kDa 
single chain glycoprotein primarily produced by the prostate epithelium [5]. The altered level of PSA 
above the cut-off value of 4 ng/ml in blood is often suspected to be linked with PCa [6,7]. However, 
increased PSA levels in blood can also be found in patients with benign prostate conditions, which 
can give rise to misdiagnosis. Even though PSA is no longer considered to be a very reliable PCa 
biomarker, there is a general consensus that it is an important marker that needs to be included in any 
panel of biomarkers to be detected for PCa diagnosis.  
A range of PSA detection methods have been developed, which employ the use of expensive 
antibodies due to their high selectivity to the antigen [8-12]. However, these methods bear high cost, 
in vivo antibody production and laborious experiments. One of the alternatives to antibodies is to 
employ aptamers. Aptamers are single stranded DNA or RNA strands that can be screened using the 
in vitro chemical process SELEX (systematic evolution of ligands by exponential enrichment) [13-
15]. Once developed, aptamers can then be easily synthesized and commercially purchased. Not only 
aptamers can bind to their target while undergoing a conformational change with strong affinity and 
specificity, they can also keep most of their functionality even after multiple regeneration steps [16]. 
They can also be easily modified with a variety of functional groups expanding their use in different 
applications [17]. Aptamers have gained significant importance in the past decade and have been 
integrated with electrochemical techniques to detect proteins, whole cells, drugs and various other 
molecules [18-22]. Electrochemical biosensors have always been in the spotlight for research since 
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they require simple instrumentation and their ease to use, low cost, high sensitivity, rapid and robust 
nature. There is a substantial number of reports in the literature on impedimetric aptasensors 
exploiting the conformational change properties of the aptamers along with other factors that change 
the impedance of the system [23-29]. PSA-specific DNA aptamer-based biosensors that have been 
reported so far, employ the use of gold nanoparticles (AuNPs) for signal enhancement. One of the two 
methods is based on optical detection for PSA aptamer conjugated with AuNPs [30]. Another is an 
electrochemical-based sensor where the surface chemistry reported uses a complex layer-by-layer 
development and using bovine serum albumin for blocking the surface to reduce non-specific binding 
[31].  
Surface modification plays a vital factor in biosensor development since it affects both sensitivity and 
selectivity. Typically, bioreceptor molecules are immobilised on gold electrode surfaces using self-
assembled monolayers (SAMs) in order to make the bioreceptor available for interaction and 
passivate the electrode to reduce non-specific interactions. One of the most accepted approaches to 
achieve this goal is by alkanethiol chemistry. Alkanethiols can be easily adsorbed and form a SAM 
[32] on a clean gold surface through gold-sulphur bonds. It is been reported that longer alkane chains 
give a more compact structure with minimal defects [33]. An important consideration is whether a 
modified electrode surface prevents non-specific binding so that it could be used for real clinical 
samples. Among various gold electrode surface modifications, 6-mercaptohexanol (MCH) has been 
widely used as a spacer molecule with enough evidence on the efficiency of the DNA biosensor signal 
output which is dependent on the spacing between the probes on the gold surface [34,35] or detection 
of PSA using aptamers [36]. A thiol-terminated sulfo-betaine spacer molecule has been reported for 
surface modification to develop lectin-based biosensors with enhanced antifouling properties [37]. 
However, to date, the use of thiol-terminated sulfo-betaine to develop aptamer-based biosensors has 
not been reported.  
In this study, a simple and potentially sensitive electrochemical aptamer-based biosensor is proposed 
using thiol-terminated sulfo-betaine as an antifouling surface chemistry. A 32 bases long DNA 
aptamer for PSA [38] has been used for as a case study. The study also reports for the first time the 
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use of electrochemical impedance spectroscopy (EIS) as a detection technique for PSA dose response 
using aptamers. The results are validated by means of surface plasmon resonance (SPR) data. 
Although a previous report employed EIS to perform interfacial surface characterization of a PSA 
aptamer-based biosensor [31], it has not been used as a technique to monitor PSA levels on 
aptasensors. The current study also compares MCH and thiol terminated sulfo-betaine for their effect 
on the sensitivity and selectivity of the fabricated impedimetric biosensors. We report the effect of 
different buffers on EIS signal change and present a debate on buffer influence on the measurement 
data, applicable to most EIS-based aptasensors. The PSA aptamer based electrochemical biosensor is 
a prospective platform for clinical applications with acceptable precision and repeatability.  
 
2. Materials and Methods 
2.1. Reagents 
PSA aptamers (thiolated PSA aptamer, 5’-HS-(CH2)6-TTT TTA ATT AAA GCT CGC CAT CAA 
ATA GCT TT-3’ and amine terminated PSA aptamer, 5’-NH2-(CH2)6- TTT TTA ATT AAA GCT 
CGC CAT CAA ATA GCT TT -3’) were synthesized by Sigma-Aldrich (Gillingham, UK). Prostate–
specific antigen was obtained from Merck Chemicals Ltd (Beeston, UK). Human serum albumin 
(HSA), 11-mercaptoundecanoic acid (MUA), 6-mercapto-1-hexanol (MCH), trisma base, potassium 
phosphate monobasic solution (1 M), potassium phosphate dibasic solution (1 M), potassium sulphate, 
potassium hexacyanoferrate (III), potassium hexacyanoferrate (II) trihydrate, 
ethylenediaminetetraacetic acid (EDTA, 0.5 M), N-hydroxysuccinimide (NHS), N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), ethanolamine, Tween 20, 
hexaammineruthenium (III) chloride and magnesium chloride were all purchased from Sigma-
Aldrich. Human glandular kallikrein 2 (hK2) was obtained from R&D Systems (Abingdon, UK). 
Thiol terminated sulfo-betaine ((R)-3-((2-(5-(1,2-dithiolan-3-
yl)pentanamido)ethyl)dimethylammonio)propane-1-sulfonate) was synthesized according to a 
previously published procedure [35]. All other reagents were of analytical grade. All aqueous 
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solutions were prepared using 18.2 MΩ cm ultra-pure water with a Pyrogard filter (Millipore, 
Feltham, UK). 
 
2.2. Apparatus 
The electrochemical measurements were performed using a µAUTOLAB III / FRA2 potentiostat 
(Metrohm Autolab, Utrecht, The Netherlands) using a three-electrode cell setup with a Hg/Hg2SO4 
(K2SO4) reference electrode (BASi, West Lafayette, IN, USA) connected via a salt bridge filled with 
0.1 M phosphate buffer (PB) containing 0.1 M KCl (pH 7.4) and a Pt counter electrode (ALS, Tokyo, 
Japan). The impedance spectrum was measured in 0.1 M PB measurement buffer with 0.1 M KCl 
containing 10 mM of the ferro/ferricyanide [Fe(CN)6]3-/4- redox couple (hexacyanoferrate II/III) in a 
frequency range from 100 kHz to 100 mHz, with a 10 mV a.c. voltage superimposed on a bias d.c. 
voltage of -0.190 V vs. Hg/Hg2SO4 (corresponding to the formal potential of the redox couple).  
Surface plasmon resonance (SPR) experiments were carried out in a dual-channel SPR7000DC from 
Reichert Technologies (Depew, NY, USA). Gold coated SPR sensors were immobilised in situ with 
the aptamer and measurements carried out in 10 mM PBS with 0.05% Tween 20 under flow 
conditions. The flow rate was kept constant at 25 µl/min upon injection of different protein 
concentrations, allowing 10 minutes for binding followed by 5 minutes for dissociation of unbound 
protein 
 
2.3. Sample preparation 
Gold disk working electrodes with a radius of 1.0 mm (CH Instruments, Austin, TX, USA) were 
cleaned using a protocol based on that reported by Keighley et al. [32]: electrodes were mechanically 
polished for 2 min with 1 µm diamond solution (Buehler, Lake Bluff, IL, USA) and thereafter for 
5 min with 50 nm alumina slurry (Buehler) on respective polishing pads (Buehler). In between each 
step 10 min sonication and rinsing in ultra-pure water was practiced in order to remove any remaining 
particles. Electrodes were then electrochemically cleaned in 0.5 M H2SO4 by scanning the potential 
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between the oxidation and reduction of gold, −0.05 V and +1.1 V versus a Hg/Hg2SO4 reference 
electrode, for 50 cycles until no further changes in the voltammogram were noticed. Finally, 
electrodes were washed with ultra-pure water. 
For the fabrication of PSA aptasensor with MCH, clean gold electrodes were exposed to 150 μl of 
mixed thiolated DNA aptamer/MCH immobilization solution for 16 h in a humidity chamber. A high 
concentration of MCH was prepared in ethanol which was diluted to working concentration in binding 
buffer and measurement buffer respectively. Prior to addition of MCH, DNA aptamers were heated to 
95°C for 10 min followed by gradual cooling over 30 min to room temperature. After immobilization, 
electrodes were rinsed with DI water to remove unattached DNA aptamers. In order to ensure 
complete thiol coverage of the gold surface, the electrodes were thereafter backfilled with 1 mM 
MCH for 1 h. Electrodes were then rinsed with ultra-pure water and placed in the measurement buffer 
for 1 h to stabilize the SAM. An optimized 1% DNA aptamer mole fraction to total thiol was used to 
fabricate the biosensor [36]. 
For the fabrication of PSA aptasensors with sulfo-betaine, clean gold electrodes were immersed in a 
1:99 ratio of two thiols, MUA:thiol terminated sulfo-betaine and incubated for 16 h. Stock solution of 
MUA was prepared in pure ethanol and stored at -20°C until use and thiol terminated sulfo-betaine 
was stored dry at the same temperature and prepared fresh before use in distilled water. Amine 
terminated DNA aptamers were immobilized using standard amine coupling reaction with the 
carboxylic groups of MUA that were activated by 0.2 M EDC and 0.05 M NHS. The electrodes were 
incubated in a mixture of EDC/NHS for 20 min followed by incubation with 1 µM amine terminated 
DNA aptamer solution in the binding buffer for 2 h leading to covalent immobilization of aptamers on 
the activated SAM. Later, the SAM was washed with DI and incubated in 1 M ethanolamine (pH 8.5) 
for 30 min to block all the un-reacted activated sites of MUA. Finally, the electrodes were rinsed with 
DI water and placed in the measurement buffer for stabilization for 1 h. The same immobilisation 
procedure was used for the SPR gold electrodes. 
For binding studies, different concentrations of PSA were prepared in the binding buffer. 100 µM 
HSA was also prepared in the binding buffer for checking for non-specific interactions. The 
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specificity of the aptamer was checked by studying its interaction with different concentrations of hk2 
in the same buffer. 
 
3. Results and Discussion 
Impedimetric aptasensors were fabricated with sulfo-betaine (see structure in Figure 1c) as a spacer 
molecule for better anti-fouling properties (Figure 1a). For comparison, aptasensors using a standard 
MCH spacer were also studied (Figure 1b).  
 
Figure 1: SAMs with DNA aptamers on a gold surface before and after incubation with PSA. 
a) thiolated aptamer with MCH; b) amine terminated aptamer with sulfo-betaine; c) structure of the 
thiol-modified sulfo-betaine. 
 
3.1. Electrochemical characterization of thiol terminated DNA aptamers with MCH 
Co-immobilization of thiol modified DNA aptamer and MCH onto gold electrodes was used to 
fabricate functional electrodes for PSA detection. A typical Nyquist plot for the system is shown in 
Figure 2a. The charge transfer resistance (Rct) of the SAM prepared was determined by fitting the 
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spectra to a Randles equivalent circuit, with a constant phase element (non-ideal capacitance), in 
parallel with the charge transfer resistance (Rct) and a Warburg element (W) that models diffusion. 
After aptamer immobilisation, Rct values of around 60 Ω cm2 are observed. Upon incubation with 
PSA, a reduction in Rct was observed indicating binding with DNA aptamers. In the example shown in 
Figure 2, Rct decreased by 15% upon interaction with 10 µg/ml of PSA. This decrease is contradictory 
to what has been reported in the literature for PSA where an increase of Rct has been observed [31], 
even though these studies used EIS mainly to characterize the bio-recognition layer and not for dose 
response determination. A reduction of Rct upon aptamer-analyte interaction has also been reported for 
a different aptasensor using a lysozyme aptamer, where the reduction in charge transfer resistance 
upon binding of lysozyme to its specific DNA aptamer was attributed to screening of DNA charges by 
the lysozyme [39]. 
 
Figure 2: Typical EIS characteristics for DNA aptamer/MCH functionalized gold electrodes in 10 mM 
ferro/ferricyanide [Fe(CN)6]3-/4- in 0.1 M phosphate buffer (PB) solution containing 0.1 M KCl 
(pH 7.4). a) Nyquist impedance plot; b) Cole-Cole complex capacitance plots at high frequencies. 
Reduction in Rct was recorded on binding of PSA with DNA aptamer in binding buffer for 30 min. 
The PSA concentration was 10 µg/ml. 
 
The reduction of charge transfer resistance could arise from two reasons. Firstly, upon binding, PSA 
might screen the charges of the DNA aptamer. Secondly, as PSA is also a charged protein, it could be 
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that more positive charges are exposed because of the protein architecture itself. Consequently, as 
there is screening of charges of DNA, there is a reduction on the electrostatic barrier to the 
ferro/ferricyanide anions towards the electrode surface, leading to lowering of the Rct value of the 
system.  
In order to evaluate the capacitance of the system, a complex capacitance was defined as: 
 ܥ∗ = ܥᇱ + j	ܥᇱᇱ ≡ ଵ
୨ன௓
= ି௓ᇲᇲ
୨ன|௓|మ + j ି௓ᇲ୨ன|௓|మ       (1) 
and calculated from the impedance data. Figure 2b shows the Cole-Cole capacitance plot at high 
frequencies before and after PSA interaction. A semi-circle is observed indicating a fast capacitive 
process, followed by a larger semi-circle due to an ultra-slow process [40], which is typical of 
impedance-based sensors using redox markers in solution [41]. No significant changes in the 
capacitance are observed upon PSA interaction; however the onset of the second semicircle appears at 
lower C′ values, which could be associated with an increase of conductive paths in the SAM/biolayer 
[42]. Considering that the impedance of the system is dominated by the electrostatic potential barrier 
of the DNA layer towards the negatively charged redox marker, the increase of conductive paths 
could be associated with a reduction on the net charge of the biolayer and, therefore, consistent with 
the hypothesis of DNA charge screening by PSA.  
 
3.2. Electrochemical characterization of amine terminated DNA aptamers with sulfo-betaine 
Electrodes fabricated with amine terminated DNA aptamers immobilized on a mixed SAM consisting 
of MUA with thiol terminated sulfo-betaine via conventional EDC/NHS coupling agents through 
amino link were characterized with the EIS technique. These functionalized electrodes were used to 
detect PSA. The EIS characteristics recorded for different PSA concentrations are presented in Figure 
3. Two semicircles are observed in the Nyquist impedance plot: a small semicircle at high 
frequencies, presumably due to relaxation effects of the SAM [41], followed by a large one at lower 
frequencies. The impedance of the system was fitted by using two RC circuits in series. The resistance 
of the first semicircle remains constant (with variations lower than 5%) throughout the experiments 
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with resistance values in the order of 250 Ω cm2, while the capacitance (Figure 3b), with initial values 
of 15 µF/cm2, shows a negligible increase for concentrations up to 25 ng/ml, after which it increases 
linearly with log[PSA] until it saturates at a value of ΔC/C ≈ 8% for 1000 ng/ml PSA. The larger 
semicircle at lower frequencies is best described with a constant phase element in parallel with the 
charge transfer resistance (Rct) of the system. Again, a negative signal change in Rct was recorded 
upon binding with PSA: Rct decreases from 8.9 kΩ cm2 after aptamer immobilisation, down to 
5.3 kΩ cm2 at the highest PSA concentration used. The low frequency capacitance remains constant 
within 1% at a value of 90 µF/cm2. The fact that sulfo-betaine is considerably longer than MCH 
explains why the charge transfer resistance values are significantly larger for the sulfo-betaine 
aptasensors.  
 
Figure 3: Typical EIS characteristics for amine terminated aptamer functionalized gold electrodes 
with sulfo-betaine for different concentrations of PSA in 10 mM ferro/ferricyanide [Fe(CN)6]3-/4- in 
0.1 M phosphate buffer (PB) solution containing 0.1 M KCl (pH 7.4). 
 
A dose response curve of Rct with different concentrations of PSA relative to blank measurements is 
shown in the inset of Figure 4. The binding curve follows a Freundlich-type of equation 
(ΔRct/Rct ∝ [PSA] n) until 1000 ng/ml, after which it slowly tends to saturation. With this configuration 
the sensitivity was increased and it was possible to detect PSA concentrations lower than 1 ng/ml. 
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However, the signal change recorded was relatively very small. The reason for such a small signal 
change could be the net effect of different processes happening at the molecular level. The first 
dominating event happening is the change in the conformation of DNA aptamers on binding with PSA 
which should result in an increase in Rct. However, our assumption is at such a low concentration of 
DNA aptamer, it is very likely that all the aptamers are already in their stable conformation leading to 
exclusion of the effect of conformational changes on Rct. In addition, there is the screening of negative 
charges of DNA aptamers upon binding with PSA resulting into reduction in Rct. Lastly, there is an 
increase in Rct because of binding of PSA molecules resulting into a further passivation of the 
electrode, which can hinder the access of the redox probes to a close distance of the electrode. The 
charges of protein also add on to Rct values, which may be creating more positive charge closer to the 
surface. Consequently, the net Rct of the system depends on the combination of all the factors.  
 
Figure 4: Charge transfer resistance dose response for amine terminated aptamer electrodes with with 
sulfo-betaine for different PSA concentrations in 0.1 M PB (pH 7.4) containing 10 mM [Fe(CN)6]3-/4- 
and 0.1 M KCl. Incubation of functionalized sensors with PSA was for 30 min. The error bars 
represent the standard deviation obtained for six samples. The line corresponds is a fit of the data to a 
Freundlich equation and serves as a guide to the eye. 
 
A high standard deviation was also observed at each sample point. Such a sample-to-sample variation 
could be a result of differences in the initial Rct values of each electrode, due to variations in the 
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number of DNA aptamers immobilized on the surface. Although for the study 1% MUA mole fraction 
to total thiol [MUA+thiol terminated sulfo-betaine] was used to prepare the first SAM layer, it should 
be noted that the final concentration of DNA aptamers will be less than 1% depending on the 
efficiency of covalent coupling via EDC/NHS. It is assumed that because of the different diffusion 
rates of MUA and sulfo-betaine as well as the added flexibility of the sulfo-betaine chain, the surface 
ratio will be different than the solution ratio. Adding to this, the efficiency of EDC/NHS coupling 
reaction also plays a vital role. As a consequence, there is a significant difference in the initial Rct 
values for different samples prepared in the same way (average value 8.95 kΩ cm2 with a standard 
deviation of 4.28 kΩ cm2). The actual variations in Rct upon PSA binding, on the other hand, are quite 
reproducible. 
The binding of the aptamer with PSA was validated by means of SPR data. Using the same surface 
immobilisation process as for the sulfo-betaine impedimetric aptasensors, the SPR signal was 
monitored upon injection of different concentrations of PSA. Figure 5 shows the SPR equilibrium 
response for each PSA concentration. A typical hyperbolic dose response is observed: 
y = ymax + c/(Kd+c) where c is the concentration and Kd the affinity constant. Fitting the data yields an 
affinity constant of Kd = 9.50 ± 0.47 ng/ml. 
 
Figure 5: Variation in the equilibrium SPR signals with respect to the baseline for different 
concentrations of PSA. Measurements were carried out in 10 mM PBS with 0.05% Tween 20. The 
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line is a fit of the data to a hyperbolic dose response equation. The error bars represent the standard 
deviation obtained for three samples. 
 
3.3. Investigation of antifouling properties and specificity of fabricated sensors 
Another key point of consideration is the antifouling efficiency of the fabricated aptasensor for its 
application with real blood samples. The antifouling efficiency depends on the quality and 
composition of the SAM. Human serum albumin (HSA) was used as a control protein to study non-
specific binding as it is one of the major constituents of human blood. Upon incubation with 100 µM 
HSA (circa 67 µg/ml), the thiol aptamer/MCH sensor showed an increase of 12.5% in the Rct value. 
Given the decrease observed with target PSA, this non-specific interaction can be distinguished from 
a true positive. However, in a more complex medium like blood this could lead to decreased 
sensitivity. Electrodes with thiol terminated sulfo-betaine surface chemistry were also studied for non-
specific adsorption. These electrodes showed a negligible change in Rct (<1%), indicating good anti-
fouling properties. SPR measurements with 100 µM HSA confirmed the low non-specific signal: an 
SPR signal of ΔRIU = 6 was observed, which is similar to the signal observed for the lowest 
concentration of PSA tested (0.5 ng/ml).  
The specificity of the aptasensors with thiol terminated sulfo-betaine was checked by incubating 
freshly prepared sensors with hK2. Both PSA and hK2 are kallikrein proteins sharing 70% homology. 
Upon incubation with 10 ng/ml and 100 ng/ml of hK2, Rct decreases by -1.1% and -1.6%, 
respectively. For comparison, decreases of -6.0% and -14.3% were observed for similar 
concentrations of PSA. These results indicate that not only the sulfo-betaine moiety effectively 
prevents non-specific interactions, but the aptamer is also highly selective towards PSA. 
 
3.4. Effect of changing buffers on stability of SAM 
Another important point to take into consideration for EIS-based aptasensors is the stability of SAM 
in different buffers. It is often reported in the literature that the binding of proteins to aptamers is 
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performed in a different buffer from the measurement buffer. Hence, we investigated if the change in 
Rct values of the fabricated sensor was due to the binding of protein and not because of buffer effects. 
Both types of fabricated PSA aptasensors were used for this study. These samples were firstly 
stabilised in 0.1 M PB (pH 7.4) containing 0.1 M KCl and then measurements taken in 0.1 M PB (pH 
7.4) containing 10 mM [Fe(CN)6]3-/4- and 0.1 M KCl. Figure 6 shows the time that electrodes can take 
to give stable Rct values without addition of any protein. It should be noted that the stabilisation time 
profile depends on the surface chemistry and buffers used. The total time for stabilisation of the 
sensor can be minimised by careful sensor design and storage conditions. However, the results here 
presented highlight the need to always check for the stabilisation of the impedance signals prior to test 
an interaction.  
 
Figure 6: Change in charge transfer resistance (Rct) of an electrode measured in 30 min intervals in 
0.1 M PB (pH 7.4) containing 10 mM [Fe(CN)6]3-/4- and 0.1 M KCl. The inset shows the effect of 
introducing a 10 mM Tris-HCl (pH 7.4) buffer containing 10 mM KCl, 10 mM MgCl2 and 0.05% 
Tween 20 for 30 min without any PSA in both sulfo-betaine/aptamer and MCH/aptamer sensors. 
Measurements were carried out in 0.1 M PB (pH 7.4) containing 10 mM [Fe(CN)6]3-/4- and 0.1 M KCl. 
The error bars represent the standard deviation obtained for four samples. 
 
Once a stable Rct has been recorded, the electrodes were then immersed in 10 mM Tris-HCl (pH 7.4) 
containing 10 mM KCl, 10 mM MgCl2 and 0.05% Tween 20 for 30 min without any PSA. The EIS 
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measurement was again recorded and the results are represented in the inset of Figure 6. It can be 
clearly seen that regardless of surface chemistry used, the buffer itself can cause instability of the 
SAM which is reflected by a change in Rct. It is possible that the positive Rct variation observed by Liu 
et al. [31] is in fact due to the change in buffers during PSA incubation and not due to binding of 
PSA. Hence, it is very important to maintain the same buffer conditions throughout the EIS 
measurement in order to obtain reliable data. 
 
4. Conclusions 
With the aim to improve diagnosis of prostate cancer, this study reports a development of a PSA 
aptasensor with antifouling chemistry to detect the biomarker in complex samples. The main focus of 
this report was to investigate the use of aptamers as a possible replacement to antibodies – a study 
which can be expanded to other PCa biomarkers. Moreover, incorporation of other molecules like 
MCH or sulfo-betaine enables optimization of the sensor surface for better detection and preventing 
non-specific binding. Different surface chemistries were investigated for their performance in the 
detection of PSA. 
This work reports a decrease in Rct upon binding of PSA to DNA aptamer. This shift is probably due 
to the screening of the charges on DNA aptamers. This work also reports for the first time the use of 
sulfo-betaine with DNA aptamers. Although the optimization of surface density was a challenge, the 
fabricated aptasensors could potentially be used to detect PSA levels lower than 1 ng/ml, which falls 
in the clinically relevant range (1-10 ng/ml). With the MCH based PSA aptasensor the lowest 
concentration of PSA that could be detected was 10 µg/ml. 
Both the PSA aptasensor fabrication processes, i.e. with MCH and sulfo-betaine, were compared for 
their capability to prevent fouling. It was observed that PSA aptasensors with MCH surface chemistry 
gave a very high non-specific binding with human serum albumin, whereas PSA aptasensor with 
sulfo-betaine surface modification showed negligible signal. Sulfo-betaine moiety can therefore be 
used as a promising feature to construct biosensors for clinical applications. 
17 
 
Furthermore, a discussion on the effects of buffer was presented. It was demonstrated for the first time 
until date that by changing the buffer conditions during the EIS measurements, instabilities of the 
SAM could take place, which can therein result in changes in Rct regardless of having the analyte in 
the solution. The study showed how important it is to perform stability tests of the fabricated 
aptasensors in order to obtain reliable data. 
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